| http://www.w3.org/ns/prov#value | - It???s certainly true that the common variants that form the bulk of the markers tested by personal genomics companies tend to be very weakly associated with disease risk, but the authors note that 23andMe and other providers are now reporting on less common genetic variants with much larger effects on disease risk (I???ve previously discussed 23andMe???s move into breast cancer gene testing).
|
